Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations

被引:52
|
作者
Kim, Tae Jung
Lee, Choon-Taek
Jheon, Sang Hoon
Park, Jeong-Soo
Chung, Jin-Haeng [1 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam 463707, Gyeonggi Do, South Korea
来源
ANNALS OF THORACIC SURGERY | 2016年 / 101卷 / 02期
关键词
EML4-ALK FUSION GENE; FACTOR RECEPTOR MUTATION; CT CHARACTERISTICS; ADENOCARCINOMA; CLASSIFICATION; FEATURES; GEFITINIB; SURVIVAL;
D O I
10.1016/j.athoracsur.2015.07.062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Radiogenomic features are predictive of anaplastic lymphoma kinase (ALK) rearrangement in surgically resected non-small cell lung cancer (NSCLC). Methods. ALK rearrangement was screened by fluorescent in situ hybridization in 497 patients with resected NSCLC. Of these, 198 patients screened for both ALK and epidermal growth factor receptor (EGFR) mutation were enrolled. Clinicopathologic findings, survival after surgical procedure, computed tomographic (CT) features, and maximum standardized uptake value according to different genotypes were investigated with univariate and multivariate analyses. A receiver operating characteristic (ROC) curve analysis was performed to quantify the predictive value of these factors. Results. The prevalence of ALK positivity in resected NSCLC was 5.0% (25 of 497). Patients with ALK rearrangement showed significant differences in terms of patient's age (p = 0.006 for ALK versus EGFR, and 0.04 for ALK versus wild type [WT]/WT, respectively), solid lesion (p = 0.0074 for ALK versus EGFR), degree of contrast enhancement (p = 0.0006 for ALK versus EGFR), and lesion margin (p = 0.0011 for ALK versus EGFR, and 0.0314 for ALK versus WT/WT, respectively) compared with EGFR mutant and WT/WT cohorts. Multivariate analysis revealed that young age, solid lesion, lobulated margin, and hypoattenuation at contrast-enhanced CT scan were independent predictors of ALK positivity (p = 0.027, 0.046, 0.001, 0.021, respectively). The area under the ROC curve of the predictive model was 0.832, which suggests good discrimination. Conclusions. ALK-rearranged lung cancer has characteristic clinical and imaging features compared with EGFR mutant or WT/WT cohorts. Our findings suggest that young age, lobulated margin, solid lesion, and hypoattenuation at contrast-enhanced CT scan are important predictors of ALK-rearranged lung cancer. (C) 2016 by The Society of Thoracic Surgeons
引用
收藏
页码:473 / 480
页数:8
相关论文
共 50 条
  • [11] Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions
    Liu, Qinghua
    Huang, Qingyan
    Yu, Zhikang
    Wu, Heming
    [J]. CLINICAL RESPIRATORY JOURNAL, 2022, 16 (03): : 216 - 225
  • [12] Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations
    Wang, Hua
    Schabath, Matthew B.
    Liu, Ying
    Han, Ying
    Li, Qi
    Gillies, Robert J.
    Ye, Zhaoxiang
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (11) : 1934 - 1940
  • [13] Development of Pericardial Effusion in Non-small Cell Lung Cancer Is Associated with the Presence of EGFR/ALK Mutations
    Nardi-Agmon, Inbar
    Zer, Alona
    Peysakhovich, Yuri
    Margalit, Ili
    Kornowski, Ran
    Peled, Nir
    Iakobishvili, Zaza
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (03): : 135 - 139
  • [14] The value of tumor volume in surgically resected non-small cell lung cancer
    Iwasaki, A
    Shirakusa, T
    Enatsu, S
    Maekawa, S
    Hamada, T
    Hamasaki, M
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (02): : 112 - 116
  • [15] EGFR/ALK Mutations in Stage III Non-small Cell Lung Cancer Patients Received Chemoradiotherapy
    Nyaw, S. F.
    Tin, W. Y.
    Lo, S. H.
    Tung, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S759 - S760
  • [16] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, Kyung-Hun
    Min, Hye Sook
    Han, Sae-Won
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Im, Seock-Ah
    Chung, Doo Hyun
    Kim, Young Tale
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    Sung, Sook Whan
    Kim, Joo Hyun
    [J]. LUNG CANCER, 2008, 60 (03) : 401 - 407
  • [17] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, K.
    Han, S.
    Min, H.
    Oh, D.
    Lee, S.
    Kim, D.
    Kim, Y.
    Kim, T.
    Heo, D.
    Bang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [18] Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer
    Jin, Ying
    Chen, Ming
    Yu, Xinmin
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [19] Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer
    Ying Jin
    Ming Chen
    Xinmin Yu
    [J]. Scientific Reports, 6
  • [20] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR MUTATIONS IN NEVER SMOKERS
    Park, Young Sik
    Park, Ju-Hee
    Lee, Jinwoo
    Lee, Sang-Min
    Lee, Chang-Hoon
    Yim, Jae-Joon
    Yoo, Chul-Gyu
    Han, Sung Koo
    Kim, Young Tae
    Heo, Dae Seog
    Kim, Young Whan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1283 - S1283